Mediclinic International PLC (LSE:MDC) - Share price


Stock Report

Mediclinic International PLC MDC

Last Price
GBX291.00

Day Change
-3.20|-1.09%

As of 15/01/2021
17:55:03 GMT | GBX
Minimum 15 Minutes Delay.

Last Close294.20p
Day Range288.40 - 299.00
Mkt Cap2.15Bil
52-Wk Range232.40 - 417.00
Yield %1.09
ISINGB00B8HX8Z88
Volume322,035
P/E16.05
P/S0.01
P/CF0.05

Share Price

Total Returns 15/01/2021

 Chg (%)  
More ...
Mediclinic International PLC4.90 
FTSE 100 TR GBP3.59
 
Financials
201820192020
More ...
Income Statement
Turnover2,876.002,932.003,083.00
Operating Profit354.00325.00324.00
Net Profit-474.00-130.00-299.00
Reported EPS-66.70-20.50-43.40
Balance Sheet
Current Assets960.001,087.001,205.00
Non Current Assets5,382.005,335.005,741.00
Total Assets6,343.006,426.006,954.00
Current Liabilities525.00584.00769.00
Total Liabilities---
Total Equity3,373.003,266.003,003.00
Cash Flow
Operating Cash Flow401.00399.00515.00
Net Change in Cash-82.0012.0067.00
Director Dealings
TradedActionNotifierPriceAmountValue
More ...
15/06/2020Transfer inMr. Petrus Jurgens Myburgh0.0027,2360.00
15/06/2020Transfer inMr. Daniel Petrus Meintjes0.0045,8110.00
08/06/2020PurchaseMr. Petrus Jurgens Myburgh63.947,500479,550.00

Company Profile

Mediclinic International PLC is engaged in providing acute care, specialist-orientated, multi-disciplinary healthcare services. It offers services such as outpatient consultation and pre-hospital emergency services, emergency centres & day case surgery.

Sector

Medical Care Facilities

Index

FTSE 250 ,FTSE 350 ,FTSE All Share

Next Event 21/05/2021

Final Results
Ratios
Comp
More ...
PER (E)0.00
Div Yld (E)1.13
PEG (E)0.00
ROCE-3.15
Op Mrgn0.11
EPS Grwth0.00
Dividends
PreviousLatest
More ...
Record Date14/06/1906/12/19
Ex-Div13/06/1905/12/19
Paid29/07/1917/12/19
Amnt4.703.20
Directors
More ...
Non-Executive Director, Senior Independent DirectorMr. Alan Grieve
Executive Director, Group Chief Financial OfficerMr. Petrus Jurgens Myburgh
Non-Executive DirectorMr. Daniel Petrus Meintjes
Executive Director, Chief Executive OfficerDr. Carel Aron van der Merwe
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2021 Morningstar. All rights reserved.